Role Summary
Associate Director, Biostatistics at Immunovant, a clinical-stage immunology company focused on autoimmune diseases. The role collaborates with internal and external stakeholders to deliver the execution of the Biostatistics strategy and participates in the rapid growth of a biotech startup.
Responsibilities
- Provide statistical inputs into protocol and clinical study report development, statistical analysis plans, interpretation of statistical analysis results, and randomization plans.
- Provide oversight and review of statistical documents for multiple clinical trials, including TLF shells, eCRFs, specifications of variable derivations, and all deliverables from outside vendors or internal programmers.
- Develop effective collaborations with others within clinical teams and partner lines (such as Statistical Programming, Data Management, Medical, Clinical Operations, and Regulatory).
- Ensure that all study level statistical activities are conducted in compliance with relevant regulatory requirements and Immunovant standards.
- Provide planning, delivery and communication of statistical analyses, data presentations, and scientific reports.
- Oversee statistics and programming vendors.
- Open to opportunities to utilize innovative statistical methodology to streamline the clinical development process and facilitate optimal decision-making.
Qualifications
- PhD or MS in Statistics, Biostatistics, Mathematics, or related field
- 5+ years (7+ years for MS) of experience in biotechnology, pharmaceutical or health related area
- Knowledge of relevant FDA, EU, ICH guidelines and regulations
- Understanding of drug development
- Demonstrated ability to collaborate with diverse sets of stakeholders
- Strong written and oral communication skills with attention to detail
- Desire to work in a fast-paced, innovative environment
- Natural collaborator who enjoys working on a cross-functional team
Additional Requirements
- Remote-based; access to ImmunovantβΓΓ΄s NYC and North Carolina offices available
- Domestic or international travel may be required (<10%)